- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有22家主力机构披露2025-12-31报告期持股数据，持仓量总计1.23亿股，占流通A股42.97%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了95%的股票
技术面评分前10的股票
近期的平均成本为15.90元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为15.90元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.90","date":1783844177,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.07.13","stock":"10.01","trade":"-0.42","ind":"-2.06"},{"date":"2026.07.10","stock":"10.01","trade":"3.20","ind":"-1.00"},{"date":"2026.07.09","stock":"-2.56","trade":"-0.42","ind":"1.65"},{"date":"2026.07.08","stock":"-2.56","trade":"-1.44","ind":"-0.49"},{"date":"2026.07.07","stock":"-6.58","trade":"-4.17","ind":"-1.26"},{"date":"2026.07.06","stock":"0.31","trade":"0.97","ind":"-0.06"},{"date":"2026.07.03","stock":"2.58","trade":"1.73","ind":"0.37"},{"date":"2026.07.02","stock":"-0.13","trade":"1.10","ind":"-2.03"},{"date":"2026.07.01","stock":"6.74","trade":"5.64","ind":"0.44"},{"date":"2026.06.30","stock":"-1.29","trade":"-1.27","ind":"0.50"},{"date":"2026.06.29","stock":"3.51","trade":"5.87","ind":"1.16"},{"date":"2026.06.26","stock":"-5.64","trade":"-4.86","ind":"-2.26"},{"date":"2026.06.25","stock":"-2.27","trade":"-1.35","ind":"0.23"},{"date":"2026.06.24","stock":"-4.46","trade":"-0.89","ind":"0.11"},{"date":"2026.06.23","stock":"3.66","trade":"3.68","ind":"-1.37"},{"date":"2026.06.22","stock":"-0.95","trade":"0.07","ind":"1.78"},{"date":"2026.06.18","stock":"-0.76","trade":"0.66","ind":"-0.43"},{"date":"2026.06.17","stock":"-2.16","trade":"-1.16","ind":"0.40"},{"date":"2026.06.16","stock":"1.06","trade":"-0.99","ind":"-0.11"},{"date":"2026.06.15","stock":"0.82","trade":"0.15","ind":"1.61"},{"date":"2026.06.12","stock":"0.82","trade":"2.07","ind":"1.12"}]
联环药业,上证指数,化学制药指数
压力支撑
该股压力位为15.67元，支撑位为14.40元。
[{"text":"\u538b\u529b\u4f4d","value":"15.67","date":1783872000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.40","date":1783872000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.2资金面打败了39%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月13日 16:51
| 机构今日流向(万元) | -1056.89 | 机构5日流向(万元) | -3394.56 |
| 机构10日流向(万元) | -1227.18 | 机构20日流向(万元) | -1691.34 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加136.31万股，其中基金净减仓1家，主力净减仓2家，暂未发现中长期投资价值。
截止2025-12-31，共22家主力机构（基金16家，一般法人3家，QFII3家），持仓量总计12267.28万股，占流通A股42.97%
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 0.42万股
减仓：3家 ，减持 3.43万股
新出现在主力名单中：11家 ，持有409.39万股
从主力名单中消失：13家 ，原持有265.42万股
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 0.42万股
减仓：3家 ，减持 3.43万股
新出现在主力名单中：11家 ，持有409.39万股
从主力名单中消失：13家 ，原持有265.42万股
消息面诊股
诊断结果：5.6消息面打败了51%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 涨停雷达：创新药+LH-1801申报+SGLT-2
2026-07-13 - 逆市拉升！多只股票涨停！A股这个赛道，发生了啥？
2026-07-10 - 聚力复盘促提升 同心攻坚谋新篇
2026-07-10 - 卫健委明确创新药入基药探索路径，创新药板块集体狂欢
2026-07-10 - 涨停雷达：创新药+LH-1801申报+扬州国资 联
2026-07-10 - 【板块异动】政策利好引爆医药赛道！化学制药板块狂飙
2026-07-10 - 江苏印发新规：到2028年，冷链寄递服务基本覆盖主
2026-07-09 - 联环药业2025年全年每10股派0.70元 股权
2026-06-29 - 第十二批集采紧盯23亿大品种！340亿市场创新高，
2026-06-26 - 喜报！联环药业5mg叶酸片通过仿制药一致性评价
2026-06-26
消息列表
| 一般消息 | 高管变动 | 连续担任公司独立董事满六年 | 2026-06-30 |
| 一般消息 | 高管变动 | 因到龄退休 | 2026-06-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-29 |
| 利好 | 分红转增 | 10派0.70元(含税) | 2026-04-21 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-21 |
| 一般消息 | 高管变动 | 工作调整 | 2026-04-17 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-02-07 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-01-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-30 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-24 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-15 |
| 一般消息 | 高管变动 | 因工作调整 | 2025-12-03 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-19 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-11-14 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-11-08 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-10-17 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-16 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 高管变动 | 连续任职期将满六年 | 2025-08-11 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：7.8行业面打败了99%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2026.07.13","price":"-2.06","value":"-0.42"},{"date":"2026.07.10","price":"-1.00","value":"3.20"},{"date":"2026.07.09","price":"1.65","value":"-0.42"},{"date":"2026.07.08","price":"-0.49","value":"-1.44"},{"date":"2026.07.07","price":"-1.26","value":"-4.17"},{"date":"2026.07.06","price":"-0.06","value":"0.97"},{"date":"2026.07.03","price":"0.37","value":"1.73"},{"date":"2026.07.02","price":"-2.03","value":"1.10"},{"date":"2026.07.01","price":"0.44","value":"5.64"},{"date":"2026.06.30","price":"0.50","value":"-1.27"},{"date":"2026.06.29","price":"1.16","value":"5.87"},{"date":"2026.06.26","price":"-2.26","value":"-4.86"},{"date":"2026.06.25","price":"0.23","value":"-1.35"},{"date":"2026.06.24","price":"0.11","value":"-0.89"},{"date":"2026.06.23","price":"-1.37","value":"3.68"},{"date":"2026.06.22","price":"1.78","value":"0.07"},{"date":"2026.06.18","price":"-0.43","value":"0.66"},{"date":"2026.06.17","price":"0.40","value":"-1.16"},{"date":"2026.06.16","price":"-0.11","value":"-0.99"},{"date":"2026.06.15","price":"1.61","value":"0.15"},{"date":"2026.06.12","price":"1.12","value":"2.07"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | - | 73.49% | 11.42% | 分 |
| 2 | 石药创新 | 61.64% | 2.23% | 6.4分 |
| 3 | 泽璟制药 | 55.63% | 1.05% | 6.5分 |
| 4 | 灵康药业 | 44.99% | 13.90% | 6.6分 |
| 5 | 亚虹医药 | 42.72% | 20.20% | 6.6分 |
| 6 | 艾力斯 | 41.61% | -9.93% | 6.7分 |
| 8 | 立方制药 | 32.80% | 25.82% | 6.8分 |
| 10 | 金石亚药 | 31.06% | 3.20% | 6.0分 |
| 12 | 百利天恒 | 29.13% | -9.22% | 5.8分 |
| 14 | - | 28.32% | 3.94% | 分 |
| 16 | 双鹭药业 | 25.14% | 3.70% | 5.9分 |
| 18 | 迪哲医药 | 21.14% | -5.17% | 6.5分 |
| 20 | 百济神州 | 20.45% | -5.92% | 5.9分 |
| 22 | 科伦药业 | 20.08% | -6.14% | 6.3分 |
| 24 | 圣诺生物 | 19.22% | -8.47% | 5.8分 |
| 26 | 首药控股 | 18.70% | -8.93% | 5.9分 |
| 28 | 哈药股份 | 17.41% | 16.67% | 6.5分 |
| 30 | 海欣股份 | 17.08% | -2.94% | 4.5分 |
| 32 | 苑东生物 | 16.58% | -7.07% | 6.2分 |
| 34 | 恒瑞医药 | 14.97% | -1.80% | 6.9分 |
| 36 | 宣泰医药 | 14.61% | -1.41% | 6.6分 |
| 38 | 普洛药业 | 13.19% | -1.46% | 6.4分 |
| 40 | ST能特 | 12.95% | 10.00% | 6.1分 |
| 42 | 一品红 | 12.23% | -2.81% | 5.9分 |
| 44 | 润都股份 | 12.02% | 3.30% | 6.5分 |
| 46 | 誉衡药业 | 11.85% | -0.33% | 6.4分 |
| 48 | 吉贝尔 | 10.99% | 2.01% | 6.2分 |
| 50 | 奥赛康 | 10.13% | -5.47% | 6.6分 |
| 52 | 花园生物 | 9.71% | -25.43% | 3.9分 |
| 54 | 共同药业 | 9.15% | -1.33% | 6.7分 |
| 56 | 兴齐眼药 | 8.98% | -3.46% | 6.6分 |
| 58 | 微芯生物 | 7.72% | -5.62% | 6.2分 |
| 60 | 翰宇药业 | 7.50% | -8.91% | 6.4分 |
| 62 | 小方制药 | 6.60% | -0.80% | 5.8分 |
| 64 | 复星医药 | 6.40% | -1.20% | 6.0分 |
| 66 | 泰恩康 | 5.78% | -7.73% | 5.8分 |
| 68 | 华纳药厂 | 5.42% | -12.45% | 5.7分 |
| 70 | 凯因科技 | 5.26% | -1.55% | 5.9分 |
| 72 | 金城医药 | 4.72% | -2.39% | 5.6分 |
| 74 | 天宇股份 | 4.57% | -6.61% | 5.8分 |
| 76 | 亚太药业 | 4.40% | -5.21% | 4.8分 |
| 78 | - | 4.34% | -8.46% | 分 |
| 80 | 海辰药业 | 4.06% | -12.70% | 5.3分 |
| 82 | 辰欣药业 | 3.47% | -1.72% | 5.5分 |
| 84 | - | 3.01% | -3.79% | 分 |
| 86 | 健康元 | 2.85% | -1.46% | 6.2分 |
| 88 | 东北制药 | 1.99% | 0.87% | 5.9分 |
| 90 | 奥锐特 | 1.81% | -3.56% | 6.1分 |
| 92 | 中关村 | 1.72% | -3.49% | 5.2分 |
| 94 | 浙江医药 | 1.36% | -5.41% | 5.6分 |
| 96 | 华仁药业 | 0.75% | 2.27% | 6.0分 |
| 98 | 北大医药 | 0.58% | -1.13% | 5.6分 |
| 100 | ST人福 | 0.35% | -1.25% | 5.6分 |
| 102 | 丽珠集团 | 0.16% | -2.24% | 6.4分 |
| 104 | 悦康药业 | 0.07% | -7.14% | 5.6分 |
| 106 | 丰原药业 | -0.18% | -0.37% | 5.5分 |
| 108 | 山河药辅 | -0.41% | -2.97% | 5.4分 |
| 110 | 九典制药 | -0.47% | -2.51% | 5.8分 |
| 112 | - | -0.67% | -8.38% | 分 |
| 114 | 上海谊众 | -1.29% | -14.11% | 5.2分 |
| 116 | 健友股份 | -1.55% | 0.26% | 6.2分 |
| 118 | 哈三联 | -1.82% | -2.89% | 5.6分 |
| 120 | 鲁抗医药 | -2.23% | 0.00% | 5.4分 |
| 122 | 民生健康 | -2.73% | -4.65% | 6.3分 |
| 124 | 华润双鹤 | -2.74% | -2.51% | 5.9分 |
| 126 | 赛托生物 | -3.47% | -5.50% | 6.1分 |
| 128 | 富士莱 | -4.00% | -4.19% | 5.8分 |
| 130 | 同和药业 | -4.26% | -5.52% | 5.9分 |
| 132 | ST惠程 | -5.04% | -4.53% | 5.5分 |
| 134 | 西点药业 | -5.82% | -4.58% | 5.8分 |
| 136 | 海森药业 | -6.10% | -4.77% | 5.2分 |
| 138 | 新和成 | -6.51% | -9.49% | 4.8分 |
| 140 | 莱美药业 | -7.19% | -6.63% | 4.7分 |
| 142 | 本立科技 | -8.49% | -7.34% | 5.8分 |
| 144 | 莎普爱思 | -9.43% | -2.58% | 5.4分 |
| 146 | 汉商集团 | -10.24% | -4.76% | 5.7分 |
| 148 | 广济药业 | -12.12% | -3.84% | 5.0分 |
| 150 | 向日葵 | -13.06% | -10.78% | 3.4分 |
| 152 | 仟源医药 | -14.85% | -5.97% | 5.3分 |
| 154 | 宏源药业 | -21.87% | -17.42% | 4.9分 |
| 156 | 常山药业 | -28.19% | 2.14% | 5.1分 |
| 158 | 通化金马 | -37.92% | -9.35% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 102/217 ， 123/217。
[{"date":"2026-03-31","value":"0.50","vol":"0.43"},{"date":"2025-12-31","value":"-7.37","vol":"-2.03"},{"date":"2025-09-30","value":"-2.57","vol":"1.53"},{"date":"2025-06-30","value":"-2.94","vol":"1.24"},{"date":"2025-03-31","value":"1.64","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.50 | -7.37 | -2.57 | -2.94 | 1.64 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"26.52","vol":"50.72"},{"date":"2025-12-31","value":"34.80","vol":"49.72"},{"date":"2025-09-30","value":"34.49","vol":"49.60"},{"date":"2025-06-30","value":"38.80","vol":"49.57"},{"date":"2025-03-31","value":"41.50","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
26.52 | 34.80 | 34.49 | 38.80 | 41.50 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 24/217 ， 136/217。
[{"date":"2026-03-31","value":"29.14","vol":"25.51"},{"date":"2025-12-31","value":"25.52","vol":"38.97"},{"date":"2025-09-30","value":"26.63","vol":"141.63"},{"date":"2025-06-30","value":"14.12","vol":"78.56"},{"date":"2025-03-31","value":"18.78","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
29.14 | 25.52 | 26.63 | 14.12 | 18.78 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-72.14","vol":"47.13"},{"date":"2025-12-31","value":"-216.84","vol":"-26.11"},{"date":"2025-09-30","value":"-137.82","vol":"-2.93"},{"date":"2025-06-30","value":"-163.65","vol":"59.61"},{"date":"2025-03-31","value":"-29.15","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-72.14 | -216.84 | -137.82 | -163.65 | -29.15 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/217 ， 27/217。
[{"date":"2026-03-31","value":"0.20","vol":"0.10"},{"date":"2025-12-31","value":"0.76","vol":"0.41"},{"date":"2025-09-30","value":"0.58","vol":"0.31"},{"date":"2025-06-30","value":"0.38","vol":"0.21"},{"date":"2025-03-31","value":"0.19","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.76 | 0.58 | 0.38 | 0.19 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.93","vol":"0.65"},{"date":"2025-12-31","value":"3.21","vol":"2.58"},{"date":"2025-09-30","value":"2.54","vol":"1.93"},{"date":"2025-06-30","value":"1.56","vol":"1.29"},{"date":"2025-03-31","value":"0.72","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.93 | 3.21 | 2.54 | 1.56 | 0.72 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-9.74","vol":"-2.81"},{"date":"2025-12-31","value":"25.17","vol":"16.49"},{"date":"2025-09-30","value":"-1.89","vol":"4.26"},{"date":"2025-06-30","value":"-15.92","vol":"2.95"},{"date":"2025-03-31","value":"-8.46","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -9.74 | 25.17 | -1.89 | -15.92 | -8.46 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.72","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"3.09","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.72 | - | 3.09 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 82/217 ， 55/217。
[{"date":"2026-03-31","value":"0.94","vol":"3.57"},{"date":"2025-12-31","value":"0.98","vol":"3.31"},{"date":"2025-09-30","value":"1.14","vol":"3.48"},{"date":"2025-06-30","value":"1.18","vol":"3.66"},{"date":"2025-03-31","value":"1.17","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.94 | 0.98 | 1.14 | 1.18 | 1.17 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.52","vol":"2.93"},{"date":"2025-12-31","value":"0.55","vol":"2.69"},{"date":"2025-09-30","value":"0.61","vol":"2.73"},{"date":"2025-06-30","value":"0.63","vol":"2.88"},{"date":"2025-03-31","value":"0.64","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.52 | 0.55 | 0.61 | 0.63 | 0.64 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 36/217 ， 15/217。
[{"date":"2026-03-31","value":"59.39","vol":"33.54"},{"date":"2025-12-31","value":"59.00","vol":"34.70"},{"date":"2025-09-30","value":"57.72","vol":"34.06"},{"date":"2025-06-30","value":"54.90","vol":"34.12"},{"date":"2025-03-31","value":"50.71","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
59.39 | 59.00 | 57.72 | 54.90 | 50.71 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.93","vol":"9.77"},{"date":"2025-12-31","value":"1.90","vol":"1.76"},{"date":"2025-09-30","value":"1.78","vol":"1.19"},{"date":"2025-06-30","value":"1.55","vol":"0.87"},{"date":"2025-03-31","value":"1.30","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.93 | 1.90 | 1.78 | 1.55 | 1.30 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.35","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.84","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.98","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]